logo

For the Inventor, By the Inventor

Stockholm, Sweden

Index Pharmaceuticals Ab


USPTO Granted Patents = 20

% Expired Patents = 65.0



Forward Citations = 27

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Oliver Von Stein (14 out of 15 patents)

silverMedal Arezou Zargari (13 out of 13 patents)

bronzeMedal Charlotte Admyre (8 out of 8 patents)

4.  Petra Von Stein (6 out of 7 patents)

5.  Lars-Göran Axelsson (4 out of 4 patents)

6.  Robert Löfberg (4 out of 5 patents)

7.  Lisa Charlotta Bandholtz (4 out of 4 patents)

8.  Peter Zerhouni (3 out of 3 patents)

9.  Nikolai Kouznetsov (3 out of 3 patents)

10.  Ann-Kristin Spiik (3 out of 3 patents)

11.  Pernilla Sandwall (2 out of 2 patents)

12.  Thomas Knittel (2 out of 2 patents)

13.  Nicolai Kouznetzov (2 out of 2 patents)

14.  Alexander Gielen (2 out of 2 patents)

15.  Patrik Andersson (2 out of 2 patents)


20 patents:

1. 11795462 - Therapy (2023-10-24),
2. 11596608 - Formulation (2023-03-07),
3. 11166975 - Cobitolimod for use in the treatment of inflammatory bowel disease (2021-11-09),
4. 10046006 - Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells (2018-08-14),
5. 9795627 - Method for prevention of colectomy (2017-10-24),
6. 9593337 - Method for identifying biologically active oligonucleotides capable of modulating the immune system (2017-03-14),
7. 9492516 - Method for prevention of colectomy (2016-11-15),
8. 9157919 - Method for identifying biologically active oligonucleotides capable of modulating the immune system (2015-10-13),
9. 8895522 - Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease (2014-11-25),
10. 8877724 - Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells (2014-11-04),
11. 8637479 - Compounds and methods for the treatment of inflammatory diseases of the CNS (2014-01-28),
12. 8592390 - Immunostimulatory method (2013-11-26),
13. 8574834 - Method for predicting the response to a therapy (2013-11-05),
14. 8569257 - Method for modulating responsiveness to steroids (2013-10-29),
15. 8410068 - Compounds for the treatment or alleviation of edema, and methods for their use (2013-04-02),
Company Overview
Index Pharmaceuticals AB is a biotechnology company based in Stockholm, Sweden, specializing in the development of innovative therapies for various medical conditions. The organization focuses on advancing drug discovery and development processes, particularly in the fields of oncology and autoimmune diseases. By leveraging cutting-edge research and technology, Index Pharmaceuticals aims to address unmet medical needs and improve patient outcomes through its proprietary therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

20 Patents

#45 in Stockholm

#324 in Sweden

#31,264 in the World

Stockholm, SE
Stockholm, Sweden

Index Pharmaceuticals Ab

Forward Citations = 27

25 inventors:

goldMedal Oliver Von Stein (14 out of 15 patents)

silverMedal Arezou Zargari (13 out of 13 patents)

bronzeMedal Charlotte Admyre (8 out of 8 patents)

4.  Petra Von Stein (6 out of 7 patents)

5.  Lars-Göran Axelsson (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Index Pharmaceuticals Ab. Retrieved from https://idiyas.com/company/index-pharmaceuticals-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…